NCT05828082 2026-03-18
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
Children's Oncology Group
Thomas Jefferson University
Indiana University
Mayo Clinic
The Ottawa Hospital
Ottawa Heart Institute Research Corporation
NYU Langone Health
University of Southern California
National Cancer Institute (NCI)
TC Erciyes University
Fox Chase Cancer Center